Search Results - "VENKETARAMAN, Vishwanath"
-
1
Analysis of the Delta Variant B.1.617.2 COVID-19
Published in Clinics and practice (21-10-2021)“…With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more…”
Get full text
Journal Article -
2
Editorial: Advances in the management of tuberculosis meningitis
Published in Frontiers in immunology (12-06-2024)Get full text
Journal Article -
3
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems
Published in International journal of molecular sciences (28-05-2021)“…Nausea and vomiting are common gastrointestinal complaints that can be triggered by diverse emetic stimuli through central and/or peripheral nervous systems…”
Get full text
Journal Article -
4
SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
Published in Infectious disease reports (30-11-2021)“…As of September 2021, there has been a total of 123,633 confirmed cases of pregnant women with SARS-CoV-2 infection in the US according to the CDC, with…”
Get full text
Journal Article -
5
Immunopathology of Pulmonary Mycobacterium tuberculosis Infection in a Humanized Mouse Model
Published in International journal of molecular sciences (01-02-2024)“…Despite the availability of antibiotic therapy, tuberculosis (TB) is prevailing as a leading killer among human infectious diseases, which highlights the need…”
Get full text
Journal Article -
6
A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
Published in International journal of molecular sciences (26-08-2020)“…(Mtb) is a highly infectious acid-fast bacillus and is known to cause tuberculosis (TB) in humans. It is a leading cause of death from a sole infectious agent,…”
Get full text
Journal Article -
7
Glutathione in HIV-Associated Neurocognitive Disorders
Published in Current issues in molecular biology (01-06-2024)“…A large portion of patients with Human Immunodeficiency Virus (HIV) have neurologic sequelae. Those with better-controlled HIV via antiretroviral therapies…”
Get full text
Journal Article -
8
TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection
Published in Frontiers in bioscience (Scholar edition) (01-03-2022)“…Tuberculosis (TB) and Coronavirus Disease-19 (COVID-19) infection are two respiratory diseases that are of particular concern epidemiologically. Tuberculosis…”
Get full text
Journal Article -
9
Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
Published in Frontiers in immunology (01-06-2023)Get full text
Journal Article -
10
Host Cell Death and Modulation of Immune Response against Mycobacterium tuberculosis Infection
Published in International journal of molecular sciences (01-06-2024)“…( ) is the causative agent of tuberculosis (TB), a prevalent infectious disease affecting populations worldwide. A classic trait of TB pathology is the…”
Get full text
Journal Article -
11
Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
Published in Frontiers in immunology (20-07-2022)Get full text
Journal Article -
12
HIV-TB Coinfection: Current Therapeutic Approaches and Drug Interactions
Published in Viruses (21-02-2024)“…The co-occurrence of human immunodeficiency virus (HIV) and tuberculosis (TB) infection poses a significant global health challenge. Treatment of HIV and TB…”
Get full text
Journal Article -
13
Role of NF-κB during Mycobacterium tuberculosis Infection
Published in International journal of molecular sciences (16-01-2023)“…( ) causes tuberculosis infection in humans worldwide, especially among immunocompromised populations and areas of the world with insufficient funding for…”
Get full text
Journal Article -
14
Editorial: Recent advancements in mycobacterial diseases research
Published in Frontiers in microbiology (16-10-2024)Get full text
Journal Article -
15
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
Published in Journal of clinical medicine (11-02-2019)“…Tuberculosis (TB) is a serious infectious disease caused by the pathogen ( ). The current therapy consists of a combination of antibiotics over the course of…”
Get full text
Journal Article -
16
Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer's Disease: The Potential Role of a Novel Nano-Compound-The Transdermal Glutathione-Cyclodextrin Complex
Published in Antioxidants (12-09-2024)“…Oxidative stress (OS) occurs from excessive reactive oxygen species or a deficiency of antioxidants-primarily endogenous glutathione (GSH). There are many…”
Get full text
Journal Article -
17
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
Published in International journal of molecular sciences (15-02-2023)“…Tuberculosis (TB) is a leading cause of mortality due to infectious disease and rates have increased during the emergence of COVID-19, but many of the factors…”
Get full text
Journal Article -
18
The Role of Glutathione in the Management of Cell-Mediated Immune Responses in Individuals with HIV
Published in International journal of molecular sciences (01-03-2024)“…Human immunodeficiency virus (HIV) is a major cause of death worldwide. Without appropriate antiretroviral therapy, the infection can develop into acquired…”
Get full text
Journal Article -
19
Mycobacterium tuberculosis -Human Immunodeficiency Virus Infection and the Role of T Cells in Protection
Published in Vaccines (Basel) (01-07-2024)“…Tuberculosis (TB), primarily caused by ( ), remains a widespread fatal health issue that becomes significantly detrimental when coupled with HIV. This study…”
Get full text
Journal Article -
20
Investigating the causes for decreased levels of glutathione in individuals with type II diabetes
Published in PloS one (19-03-2015)“…Tuberculosis (TB) remains an eminent global burden with one third of the world's population latently infected with Mycobacterium tuberculosis (M. tb)…”
Get full text
Journal Article